hotspot -WSS

hotspot

author：focus 2025-08-28 08:40:02 - browse：464

Demetre Daskalakis, who has spent the past year in Washington as deputy director of the White House’s mpox response, was named acting director of the National Center for Immunization and Respiratory Diseases. MANDEL NGAN/AFP via Getty Images

The new director of the Centers for Disease Control and Prevention, Mandy Cohen, is overhauling the leadership of the CDC center that led the agency’s Covid-19 response.

In an announcement to staff issued Tuesday, Cohen said José Romero, who headed the National Center for Immunization and Respiratory Diseases for the past 14 months, would be leaving the CDC at the end of August.

“I want to thank him for his service to this agency and our country,” Cohen said in the memo to staff, a copy of which was obtained by STAT.

Replacing Romero, at least on an acting basis, is Demetre Daskalakis, who has spent the past year in Washington as deputy director of the White House’s national mpox response team. The White House operation is being wound down and will be completed by the end of August.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

Daskalakis, who has spent much of his career working on HIV prevention and control, was director of the CDC’s Division of HIV/AIDS Prevention in the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. For much of 2021, he led the CDC’s Covid-19 vaccine task force.

Romero, who was Arkansas’ secretary of health from 2020 to 2022, joined the CDC in June 2022 in the center director role. Previously he served on, and was chair of, the CDC’s expert vaccine panel, the Advisory Committee on Immunization Practices.

Two other high-ranking officials in NCIRD are being moved to other centers within the agency. Sam Posner, who served as acting director of the center in the second year of the pandemic, and has been principal deputy director since Romero’s hiring, is going to be acting director of the National Center for Injury Prevention and Control.

At NCIRD, Posner had replaced Nancy Messonnier, who ran afoul of the Trump administration early in the pandemic when she publicly warned in early March 2020 that the rapidly spreading virus was going to dramatically change lives. Messonnier left the CDC in the spring of 2021 and is now the dean of the Gillings School of Global Public Health at the University of North Carolina.

Kristin Pope, deputy director of NCIRD, is going to the new Center for Forecasting and Analytics.

Previous article： Medicare details structure of new drug price negotiation program
Next article： Shionogi licenses Pompe disease therapy from Maze Therapeutics

hotspot

WSS

Dairy farmers resist CDC push for PPE against bird flu virus

Sanofi strikes deal with Novavax, boosting the vaccine maker

In same hospitals, Black patients receive fewer opioids than white patients

Drastic changes should bring profitability, startup health insurers say

First recipient of genetically engineered pig kidney has died

The best solution to the drug shortages problem

focus

hotspot

Sign up for D.C. Diagnosis

leisure time

In Memoriam: Notable people who died in 2023

What to know about Virgin Galactic's 1st mission taking paying customers to space

Psychedelics group wrestles with new pharma identity

South Korea throws huge K

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Bird flu outbreak in cows is latest avian flu curveball

Guidelines to prevent youth baseball injuries need more muscle

Medicare says breakthrough device reimbursement rule to come by summer

ChatGPT in medicine: STAT answers readers' burning questions

Police still searching for prisoner who escaped from NYC hospital

Wikipedia

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

In same hospitals, Black patients receive fewer opioids than white patients

Study: AI not yet building 'n

Making AI in medicine accessible to smaller, and rural hospitals

NIH trials fail to test meaningful long Covid therapies, experts say

H5N1 communication has been strictly for the birds

explore

hotspot

hotspot

focus